End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
366.33 CNY | -1.66% | +0.92% | +36.73% |
Oct. 25 | APT Medical Inc. Reports Earnings Results for the Nine Months Ended September 30, 2024 | CI |
Sep. 23 | APT Medical Inc.(XSSC:688617) added to FTSE All-World Index | CI |
Capitalization | 36.11B 4.97B 4.7B 4.36B 3.89B 7.02B 422B 7.69B 54.2B 20.01B 173B 18.67B 18.26B 751B | P/E ratio 2024 * |
51.7x | P/E ratio 2025 * | 39.2x |
---|---|---|---|---|---|
Enterprise value | 36.11B 4.97B 4.7B 4.36B 3.89B 7.02B 422B 7.69B 54.2B 20.01B 173B 18.67B 18.26B 751B | EV / Sales 2024 * |
16.9x | EV / Sales 2025 * | 12.9x |
Free-Float |
-
| Yield 2024 * |
0.5% | Yield 2025 * | 0.65% |
1 day | -2.99% | ||
1 week | +2.62% | ||
Current month | +2.73% | ||
1 month | +9.89% | ||
3 months | +5.86% | ||
6 months | +20.94% | ||
Current year | +39.04% |
Director | Title | Age | Since |
---|---|---|---|
Zheng Hui Cheng
CEO | Chief Executive Officer | 60 | 2016-07-31 |
Zhen Hua Dai
DFI | Director of Finance/CFO | 56 | 2019-11-08 |
Yu Chen Qiu
CTO | Chief Tech/Sci/R&D Officer | 59 | 2010-12-31 |
Manager | Title | Age | Since |
---|---|---|---|
Yue Feng Xiao
BRD | Director/Board Member | 61 | 2019-11-08 |
Li Jun Xia
BRD | Director/Board Member | 48 | 2019-11-08 |
Zheng Hui Cheng
CHM | Chairman | 60 | 2014-04-30 |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
-2.99% | +2.62% | +41.29% | +72.98% | 4.97B | ||
-0.01% | +0.01% | +92.19% | +84.13% | 12.57B | ||
+1.53% | -1.63% | +7.51% | -3.57% | 9.24B | ||
-0.16% | -1.26% | +62.44% | -38.75% | 9.08B | ||
-0.49% | -1.76% | -6.35% | +3.62% | 4.73B | ||
-1.30% | -2.51% | +0.21% | -3.63% | 4.61B | ||
+0.12% | +3.69% | -22.42% | -54.75% | 4.35B | ||
+2.47% | -4.02% | +129.20% | -67.36% | 3.1B | ||
+4.52% | +2.44% | -15.32% | -33.29% | 3.13B | ||
-2.15% | -1.53% | -31.21% | -57.57% | 1.55B | ||
Average | +0.15% | -0.57% | +25.75% | -9.82% | 5.73B | |
Weighted average by Cap. | +0.15% | -0.60% | +37.99% | +6.91% |
2024 * | 2025 * | |
---|---|---|
Net sales | 2.13B 294M 277M 257M 230M 415M 24.91B 454M 3.2B 1.18B 10.22B 1.1B 1.08B 44.34B | 2.81B 386M 365M 339M 302M 546M 32.79B 598M 4.21B 1.55B 13.45B 1.45B 1.42B 58.36B |
Net income | 703M 96.78M 91.48M 84.87M 75.68M 137M 8.21B 150M 1.06B 389M 3.37B 363M 356M 14.62B | 928M 128M 121M 112M 99.95M 181M 10.85B 198M 1.39B 514M 4.45B 480M 470M 19.31B |
Net Debt | - | - |
Date | Price | Change | Volume |
---|---|---|---|
24-12-09 | 366.33 ¥ | -1.66% | 824,669 |
24-12-09 | 372.52 ¥ | -2.99% | 658,226 |
24-12-06 | 384.00 ¥ | +1.71% | 693,532 |
24-12-05 | 377.56 ¥ | -0.64% | 412,080 |
24-12-04 | 380.00 ¥ | +1.74% | 692,787 |
End-of-day quote Shanghai S.E., December 08, 2024
More quotesAnnual profits - Rate of surprise
- Stock Market
- Equities
- 688617 Stock